Work

MM-096: Isatuximab Short-Duration Fixed-Volume Infusion Combination Therapy for Relapsed/Refractory Multiple Myeloma: Final Results of a Phase 1b Feasibility/Safety Study

Year: 2020

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(20)30923-x

Authors: Saad Usmani, Chatchada Karanes, William Bensinger, Anita D'Souza, Noopur Raje, Sascha Tuchman, Douglas Sborov, Dheepak Kanagavel, Rao Saleem, Franck Dubin, Frank Campana, Paul Richardson

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3110857052

Cites:

Cited by: 4

Related to: 10